Sagimet Biosciences Announces Poster and Oral Presentations at the Fueling MASH: Metabolic Drivers and Inflammatory Crosstalk Keystone Symposium and Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Charting the S&P 500: Did the Bulls Pull Off the 'Great Escape'?

US Market's Hidden Gems: 3 Promising Small Caps

Xeris Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - April 3, 2026

Amkor Technology to Announce First Quarter 2026 Financial Results on April 27, 2026

Inhibikase Therapeutics, Inc. (NASDAQ:IKT) Given Consensus Rating of "Buy" by Analysts